Related Experiment Videos
Gastric mucosal protection by spizofurone
European Journal of Pharmacology
|May 28, 1985
Summary
Spizofurone (AG-629) demonstrates significant gastric mucosal protection in rats by inhibiting lesions induced by ethanol, indomethacin, and aspirin. It also enhances the protective effects of prostaglandin E2, suggesting a potent anti-ulcer mechanism.
Area of Science:
- Gastroenterology
- Pharmacology
- Toxicology
Background:
- Gastric mucosal damage is a significant health concern.
- Understanding protective mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the gastroprotective effects of spizofurone (AG-629) against various damaging agents in a rat model.
- To explore the potential interaction of spizofurone with prostaglandin E2.
Main Methods:
- Oral and intraperitoneal administration of spizofurone in rats.
- Induction of gastric lesions using ethanol, indomethacin, and aspirin.
- Measurement of gastric potential difference and ion fluxes.
- Assessment of prostaglandin E2 potentiation.
Main Results:
- Spizofurone significantly inhibited ethanol-induced gastric lesions (ED50 = 6.5 mg/kg orally).
- It protected against indomethacin-induced ulcers and aspirin-induced lesions.
- Spizofurone potentiated the protective effect of prostaglandin E2 and preserved the mucosal barrier.
Conclusions:
- Spizofurone exhibits potent gastroprotective properties, similar to prostaglandin E2.
- Its mechanism involves preserving the gastric mucosal barrier.
- Spizofurone is a promising agent for managing gastric ulcers.